Eurofins Scientific (ERFSF) News Today $46.99 -1.91 (-3.91%) (As of 10/31/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period Eurofins Scientific SE (OTCMKTS:ERFSF) Short Interest UpdateEurofins Scientific SE (OTCMKTS:ERFSF - Get Free Report) was the recipient of a large drop in short interest in October. As of October 15th, there was short interest totalling 246,600 shares, a drop of 17.4% from the September 30th total of 298,500 shares. Based on an average daily volume of 1,400 shares, the days-to-cover ratio is currently 176.1 days.October 30 at 12:34 AM | marketbeat.comEurofins Confirms Profitability and Cash Flow Objectives for 2024 Leading to Higher Profit Margins in Spite of the Impact of the Post-COVID Reset of BioPharma PipelinesOctober 22, 2024 | businesswire.comEurofins Shares Slide After Revenue Target CutOctober 22, 2024 | marketwatch.comEurofins Announces Results of Cash Audit Confirming Its FY 2023 Cash Balance and the High Integrity of Its Systems and Controls and Refutes Muddy Waters’ Allegations ...October 22, 2024 | businesswire.comEurofins says independent audit refutes short seller's allegationsOctober 22, 2024 | msn.comEurofins Discovery Extends AI-powered Integrated Drug Discovery CollaborationOctober 10, 2024 | tmcnet.comBerenberg Bank Reaffirms Their Buy Rating on Eurofins Scientific (0MV5)October 7, 2024 | markets.businessinsider.comEurofins testing labs buys building to occupy in Rancho CordovaOctober 1, 2024 | bizjournals.comEurofins Scientific SE (ERFSF) Q2 2024 Earnings Call TranscriptJuly 25, 2024 | seekingalpha.comEurofins CDMO Alphora Inc. Announces the Launch of Expanded Drug Product Analytical LaboratoryMay 29, 2024 | finance.yahoo.comEurofins Scientific SE: Purchases of Own Shares From the 20th of May 2024 to the 24th of May 2024May 27, 2024 | finance.yahoo.comEurofins: Purchases of own shares from the 13th of May 2024 to the 17th of May 2024May 21, 2024 | finance.yahoo.comEurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2024May 15, 2024 | finance.yahoo.comThe Eurofins Network Expands Battery Testing Services, Supporting Client Acceleration of Battery InnovationMay 13, 2024 | finance.yahoo.comFDA Experts Weigh In On Incannex's CannQuit-O With Feedback On CBD As Treatment For Opioid Use DisorderMay 7, 2024 | msn.comEurofins Scientific SE: Purchases of Own Shares From the 29th of April 2024 to the 3rd of May 2024May 6, 2024 | finance.yahoo.comEurofins Scientific SE: Purchases of Own Shares From the 25th to the 26th of April 2024April 29, 2024 | finance.yahoo.comEurofins Achieves Organic Growth of 6.8% in Q1 2024, Ahead of Its ObjectivesApril 24, 2024 | finance.yahoo.comEurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2024April 5, 2024 | finance.yahoo.comThe Eurofins Network Expands Its Offering in Renal and Transplant Testing in the United States With the Acquisition of Ascend Clinical LLCApril 3, 2024 | finance.yahoo.comEurofins: Purchases of Own Shares from the 18th to the 22th of March 2024March 25, 2024 | finance.yahoo.comEurofins: Convening Notice of the Shareholders to the Annual Ordinary General Meeting and an Extraordinary General Meeting of the Company Valid as an Information Notice for the BondholdersMarch 25, 2024 | finance.yahoo.comEurofins: Purchases of Own Shares From the 11th to the 15th of March 2024March 18, 2024 | finance.yahoo.comEurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 29 February 2024March 12, 2024 | finance.yahoo.comEurofins: Purchases of Own Shares From the 5th to the 8th of March 2024March 11, 2024 | finance.yahoo.comEUROFINS SCIENT (ERFSF) Upgraded to Buy: What Does It Mean for the Stock?March 8, 2024 | msn.comEurofins Discovery Introduces Innovative DiscoveryAI SAFIRE: A New AI-Driven Platform for Drug Discovery Trained Using Proprietary DatasetsFebruary 29, 2024 | finance.yahoo.comEurofins Scientific reports FY resultsFebruary 27, 2024 | msn.comEurofins Delivers Strong Margin Improvement and Cash Generation in H2 2023 and Annual Results in Line With Its 2023 Objectives. Remains Confident to Achieve Its 2027 Objectives.February 27, 2024 | finance.yahoo.comEurofins: Purchases of Own Shares from the 12th to the 14th of February 2024February 19, 2024 | finance.yahoo.comEurofins Scientific SE: Purchases of Own Shares from the 5th to the 9th of February 2024February 12, 2024 | finance.yahoo.comEurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 January 2024February 7, 2024 | finance.yahoo.comEurofins: Purchases of Own Shares From the 29th of January to the 2nd of February 2024February 5, 2024 | finance.yahoo.comEurofins Environment Testing in Sacramento, CA in Partnership with EPA Region 10 and EPA’s Office of Water Published Draft Method 1634, an Analytical Procedure to Test for 6PPD-Quinone in Surface and StormwaterFebruary 2, 2024 | finance.yahoo.comEurofins: Purchases of Own Shares From the 22th of January to the 26th of January 2024January 29, 2024 | finance.yahoo.comGiverny Capital Asset Management Q4 2023 LetterJanuary 28, 2024 | seekingalpha.comEurofins: Purchases of Own Shares From the 15th of January to the 19 of January 2024January 22, 2024 | finance.yahoo.comEurofins Scientific SE (0MV5)January 18, 2024 | uk.investing.comEurofins: Purchases of Own Shares From the 12th of January 2024January 15, 2024 | finance.yahoo.comEurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 December 2023January 4, 2024 | finance.yahoo.comTracking Ruane, Cunniff & Goldfarb's Portfolio - Q3 2023 UpdateDecember 20, 2023 | seekingalpha.comEurofins Reinforces Its Agroscience Contract Research Services by Acquiring SGS’ Crop Science OperationsDecember 18, 2023 | finance.yahoo.comSGS SA: A Defensive, High-Quality Business Finally Trading At A Fair Price Once AgainDecember 14, 2023 | seekingalpha.comEurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2023December 7, 2023 | finance.yahoo.comEurofins Scientific Announces the Acquisition of Labor 3, Further Expanding Its Offering to the Food and Feed Market in Brazil and the Presence of Eurofins Laboratories in Latin AmericaNovember 16, 2023 | finance.yahoo.comEurofins Scientific Announces the Acquisition of Quasfar, Establishing a Presence in Colombia and Expanding the Presence of Eurofins Laboratories in Latin AmericaNovember 16, 2023 | finance.yahoo.comEurofins ScientificNovember 7, 2023 | fortune.comEurofins: Purchases of Own Shares From October, the 30th to November, the 3rd 2023November 6, 2023 | finance.yahoo.comEurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 October 2023November 3, 2023 | finance.yahoo.comEurofins: Purchases of Own Shares From October, the 25st to October, the 27th 2023October 30, 2023 | finance.yahoo.com Get Eurofins Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for ERFSF and its competitors with MarketBeat's FREE daily newsletter. Email Address True paradigm shift (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. ERFSF Media Mentions By Week ERFSF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ERFSF News Sentiment▼1.450.68▲Average Medical News Sentiment ERFSF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ERFSF Articles This Week▼20▲ERFSF Articles Average Week Get Eurofins Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for ERFSF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OLCLY News SVNDY News ASHTY News CHCJY News SUHJY News SWRAY News KHNGY News AMKBY News DSCSY News SSEZY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ERFSF) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eurofins Scientific SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Eurofins Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
